Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision tag was added (v3.5.4) and the previous tag (v3.5.3) was removed, indicating a minor update to the study record in the revision history.
    Difference
    0.1%
    Check dated 2026-05-15T09:19:50.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    This update changes the site’s visible revision/version indicator from v3.5.2 to v3.5.3 without altering the trial’s study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:13:43.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. There are no user-facing content changes indicated.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:01.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:31.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T00:26:24.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; older Revision: v3.4.1 and the government funding notice have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:52:22.000Z thumbnail image

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.